GetTopicDetailResponse(id=aeaa6861558, topicName=珀金埃爾默, introduction=珀金埃爾默, content=null, image=null, comments=5, allHits=1105, url=https://h5.medsci.cn/topic?id=68615, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=67055, tagList=[TagDto(tagId=67055, tagName=珀金埃爾默)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2041281, encodeId=599920412818a, content=<a href='/topic/show?id=aeaa6861558' target=_blank style='color:#2F92EE;'>#珀金埃爾默#</a>, objectTitle=珀金埃爾默以52.5億美元收購抗體和試劑領(lǐng)導(dǎo)者BioLegend，發(fā)力臨床診斷與食品安全檢測, objectType=article, longId=214893, objectId=c029214893ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c029214893ac, replyNumber=0, likeNumber=114, createdTime=2021-12-03, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c029214893ac, moduleTitle=珀金埃爾默以52.5億美元收購抗體和試劑領(lǐng)導(dǎo)者BioLegend，發(fā)力臨床診斷與食品安全檢測, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c029214893ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041280, encodeId=667f20412807d, content=<a href='/topic/show?id=aeaa6861558' target=_blank style='color:#2F92EE;'>#珀金埃爾默#</a>, objectTitle=珀金埃爾默的Horizon Discovery CHOSOURCE細(xì)胞系支持泰諾麥博開發(fā)世界**進(jìn)入臨床試驗(yàn)的破傷風(fēng)毒素mAb藥物, objectType=article, longId=206909, objectId=b7b020690985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7b020690985, replyNumber=0, likeNumber=103, createdTime=2021-02-28, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7b020690985, moduleTitle=珀金埃爾默的Horizon Discovery CHOSOURCE細(xì)胞系支持泰諾麥博開發(fā)世界**進(jìn)入臨床試驗(yàn)的破傷風(fēng)毒素mAb藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b7b020690985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041279, encodeId=f36820412e901, content=<a href='/topic/show?id=aeaa6861558' target=_blank style='color:#2F92EE;'>#珀金埃爾默#</a>, objectTitle=珀金埃爾默“展”新亮相中華醫(yī)學(xué)會(huì)第十四次全國檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議, objectType=article, longId=148671, objectId=6eac1486e1c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eac1486e1c8, replyNumber=0, likeNumber=83, createdTime=2019-02-05, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eac1486e1c8, moduleTitle=珀金埃爾默“展”新亮相中華醫(yī)學(xué)會(huì)第十四次全國檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6eac1486e1c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041278, encodeId=588320412e84e, content=<a href='/topic/show?id=aeaa6861558' target=_blank style='color:#2F92EE;'>#珀金埃爾默#</a>, objectTitle=85億！珀金埃爾默收購歐蒙醫(yī)學(xué), objectType=article, longId=124694, objectId=4f2812469439, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f2812469439, replyNumber=0, likeNumber=96, createdTime=2018-10-30, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f2812469439, moduleTitle=85億！珀金埃爾默收購歐蒙醫(yī)學(xué), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f2812469439)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041277, encodeId=919e20412e720, content=<a href='/topic/show?id=aeaa6861558' target=_blank style='color:#2F92EE;'>#珀金埃爾默#</a>, objectTitle=珀金埃爾默完成歐蒙13億美金收購 強(qiáng)化體外診斷市場領(lǐng)導(dǎo)地位, objectType=article, longId=124732, objectId=fef7124e32d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef7124e32d4, replyNumber=0, likeNumber=105, createdTime=2018-11-10, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef7124e32d4, moduleTitle=珀金埃爾默完成歐蒙13億美金收購 強(qiáng)化體外診斷市場領(lǐng)導(dǎo)地位, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fef7124e32d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
